Skip to main content

Multiple Testing and Combined Endpoints

  • Chapter
Statistical Reasoning in Medicine
  • 1333 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Moyé LA (2003) Multiple Analyses in Clinical Trials: Fundamentals for Investigators New York: Springer.

    MATH  Google Scholar 

  2. Nester, MR, (1996) An applied statistician’s creed Applied Statistics 45: 4401–410.

    Article  MathSciNet  Google Scholar 

  3. Rothman, RJ (1990) No adjustments are needed for multiple comparisons Epidemiology 1:43–46.

    Article  Google Scholar 

  4. Fisher, LD, Moyé LA (1999) Carvedilol and the Food and Drug Administration Approval Process: An Introduction Controlled Clinical Trials 20:1–15.

    Article  Google Scholar 

  5. Fisher LD (1999) Carvedilol and the FDA approval process: the FDA paradigm and reflections upon hypothesis testing Controlled Clinical Trials 20:16–39.

    Article  Google Scholar 

  6. Moyé LA (1999) P-Value Interpretation in Clinical Trials The Case for Discipline Controlled Clinical Trials 20:40–49.

    Article  Google Scholar 

  7. Hochberg Y, Tamhane AC (1987) Multiple Comparison Procedures, New York, Wiley.

    Book  MATH  Google Scholar 

  8. Westfall PH, Young SS (1993) Resampling Based Multiple Testing: Examples and Methods for P-Value Adjustment New York: Wiley.

    Google Scholar 

  9. Miller RG (1981) Simultaneous Statistical Inference, 2nd ed. New York Springer.

    MATH  Google Scholar 

  10. Adams C (2002) At FDA, approving cancer treatments can be an ordeal The Wall Street Journal December 11, p 1.

    Google Scholar 

  11. Senn S (1997) Statistical Issues in Drug Development Chichester, Wiley, section 15.2.1.

    Google Scholar 

  12. Simes, RJ (1986) An improved Bonferroni procedure for multiple tests of significance Biometrika 73:819–827.

    Article  MathSciNet  Google Scholar 

  13. Holm, S (1979) A simple sequentially rejective multiple test procedures Scandinavian Journal of Statistics 6:65–70.

    MATH  MathSciNet  Google Scholar 

  14. Hommel, G (1988) A stepwise rejective multiple test procedure based on a modified Bonferroni test Biometrika 75:383–386.

    Article  MATH  Google Scholar 

  15. Shaffer, JP (1986) Modified sequentially rejective multiple test procedures. Journal of the American Statistical Association 81:826–831.

    Article  MATH  Google Scholar 

  16. Zhang J, Qwuan H, Ng J, Stapanavage ME (1997) Some statistical methods for multiple endpoints in clinical trials Controlled Clinical Trials 18: 204–221.

    Article  Google Scholar 

  17. Westfall PH, Young SS, Wright SP (1993) Adjusting p-values for multiplicity Biometrics 49:941–945.

    Article  Google Scholar 

  18. Westfall, PH, Young, S P-value adjustments for mulitple tests in multivariate binomial models Journal of the American Statistical Association 84:780–786.

    Google Scholar 

  19. Westfall PH, Krishnen A, Young, SS (1998) Using prior information to allocate significance levels for multiple endpoints Statistics in Medicine 17:2107–2119.

    Article  Google Scholar 

  20. Meinert, CL (1986) Clinical Trials Design, Conduct, and Analysis, New York: Oxford University Press.

    Google Scholar 

  21. Piantadosi, S (1997), Clinical Trials: A Methodologic Perspective New York: John Wiley.

    Google Scholar 

  22. Moyé LA, Davis BR, Hawkins CM (1992) Analysis of a clinical trial involving a combined mortality and adherence dependent interval censored endpoint. Statistics in Medicine 11:1705–1717.

    Article  Google Scholar 

  23. Transcript of the Cardiovascular and Renal Drugs Advisory Committee to the FDA Captopril. February 16, 1993.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Moyé, L.A. (2006). Multiple Testing and Combined Endpoints. In: Statistical Reasoning in Medicine. Springer, New York, NY. https://doi.org/10.1007/978-0-387-46212-7_10

Download citation

Publish with us

Policies and ethics